| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/03/2003 | CA2451002A1 Cytochrome p-450 gene cluster from rhodococcus ruber and uses thereof in ether fuel cleavage |
| 01/03/2003 | CA2450969A1 Nucleic acid-associated proteins |
| 01/03/2003 | CA2450925A1 G-protein coupled receptors |
| 01/03/2003 | CA2450921A1 Protein modification and maintenance molecules |
| 01/03/2003 | CA2450792A1 Homoaconitase as a target for fungicides |
| 01/03/2003 | CA2450577A1 Methods for the manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes |
| 01/03/2003 | CA2448547A1 Metabolic controlled fermentation process for pseudomonic acid production |
| 01/03/2003 | CA2446218A1 Polypeptides derived from retinoic acid-related orphan receptor (ror),and their applications |
| 01/02/2003 | US20030005488 Propagation of fungal foods; generate nutrient broth, inoculate with fingus, propagate and recover fungal nutrients |
| 01/02/2003 | US20030005478 Methods |
| 01/02/2003 | US20030004327 Cerebellum and embryo specific protein |
| 01/02/2003 | US20030004324 31 human secreted proteins |
| 01/02/2003 | US20030004323 Novel antigen constructs useful in the detection and differention of antibodies to hiv |
| 01/02/2003 | US20030004317 Nucleic acids encoding anti-human alphanubeta3 and alphanubeta5 antibodies |
| 01/02/2003 | US20030004310 Culture product |
| 01/02/2003 | US20030004306 Fluorescent protein |
| 01/02/2003 | US20030004114 Method of inhibiting fungal growth |
| 01/02/2003 | US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 01/02/2003 | US20030003566 Cell line preparing and producing ovine adenovirus vectors |
| 01/02/2003 | US20030003562 Mucleotide sequences coding polypeptide for use in the diagnosis of cancer |
| 01/02/2003 | US20030003561 Nucleotide sequences coding polypeptide for use in the baking and detergents |
| 01/02/2003 | US20030003558 Nucleotide sequences coding enzymatic polypeptide for use in the generation of medicine, animal nutrients and foods |
| 01/02/2003 | US20030003553 Rhizopus for use in generation of lactic acids |
| 01/02/2003 | US20030003551 Method for producing dihydroxyacetone-3-phosphate |
| 01/02/2003 | US20030003550 Microorganism for use in the generation of glutamine; for use in maintaining liver health |
| 01/02/2003 | US20030003548 Nucleotide sequences for use in the generation of animal nutrition, foods, pharmacology and human medicine |
| 01/02/2003 | US20030003545 Nucleotide sequences coding polypeptide for use in the treatment of immunological defects |
| 01/02/2003 | US20030003543 Methods and applications for efficient genetic suppressor elements |
| 01/02/2003 | US20030003541 Nucleotide sequences coding peptide for use in the treatment of skin, brain and eye disorders |
| 01/02/2003 | US20030003535 Single chain class I major histo-compatibility complexes |
| 01/02/2003 | US20030003532 Novel nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 01/02/2003 | US20030003529 Vitro modification of glycosylation patterns of recombinant glycopeptides |
| 01/02/2003 | US20030003528 Generation of carotenoid compound; obtain gnetically engineeered cell, incubate with carbon substrate, recover carotene compound |
| 01/02/2003 | US20030003525 Novel promoter of gene expression |
| 01/02/2003 | US20030003511 Closure of bacterial ghost |
| 01/02/2003 | US20030003508 Serological diagnostic method with rickettsia pulicis bacterium |
| 01/02/2003 | US20030003477 Nucleotide sequences coding polypeptides for use in the treatment of nervous system, kidney, muscle, allergic and cancer disorders |
| 01/02/2003 | US20030003472 Detection of genetic aberration in sample; obtain nucleotide sequences, incubate with oligonucleotides, detect aberration in hybridization, presence of aberration indicates variablity in nucleotide sequences |
| 01/02/2003 | US20030003471 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants |
| 01/02/2003 | US20030003466 Artificial mammalian chromosome |
| 01/02/2003 | US20030003462 Novel human interleukin-like proteins and polynucleotides encoding them |
| 01/02/2003 | US20030003452 Polymerase for use in the treatment of infections, respiratory, blood, alzheimer's, muscular and cancerous disorders |
| 01/02/2003 | EP1270744A1 Reporter gene construct for the detection of HIV rev and HIV tat |
| 01/02/2003 | EP1270741A1 Nucleotide sequences involved in plant disease resistance |
| 01/02/2003 | EP1270730A1 Process for producing polypeptide having disulfide bond |
| 01/02/2003 | EP1270728A1 Process for producing avermectin derivative |
| 01/02/2003 | EP1270727A1 Salutaridinol 7-O-acetyltransferase and derivatives thereof |
| 01/02/2003 | EP1270724A2 Guanosine triphosphate-binding protein coupled receptors |
| 01/02/2003 | EP1270722A1 Cytochrome p-450 gene cluster from rhodococcus ruber and uses thereof in ether fuel cleavage |
| 01/02/2003 | EP1270720A2 Activated rec-D-Hydantoinases |
| 01/02/2003 | EP1270717A1 Chlamydospores and process for producing the same |
| 01/02/2003 | EP1270591A1 Transgenic cells and a method for detecting disruptors for androgens by using said transgenic cells |
| 01/02/2003 | EP1270589A1 Novel leukotriene b4 receptor |
| 01/02/2003 | EP1270517A1 Method for direct clarification of ground water polluted with nitrate |
| 01/02/2003 | EP1269849A1 A method for preventing plant disease |
| 01/02/2003 | EP1268844A1 Modulating production of pneumococcal capsular polysaccharide |
| 01/02/2003 | EP1268824A2 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use |
| 01/02/2003 | EP1268823A2 Methods and cells for expression of recombinant protein products |
| 01/02/2003 | EP1268822A2 Recombinant iron uptake proteins |
| 01/02/2003 | EP1268820A2 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 01/02/2003 | EP1268819A2 Muskmelon (cucumis melo) hydroperoxide lyase and uses thereof |
| 01/02/2003 | EP1268817A1 Human pyruvate dehydrogenese phosphatase |
| 01/02/2003 | EP1268816A2 Calcium-binding regulatory subunit |
| 01/02/2003 | EP1268813A2 Thermophilic polymerase iii holoenzyme |
| 01/02/2003 | EP1268812A2 Vectors for gene therapy |
| 01/02/2003 | EP1268808A1 Mutants of lactobacillus casei defective in carbon catabolism regulation |
| 01/02/2003 | EP1268805A2 Receptors for hypersensitive response elicitors and uses thereof |
| 01/02/2003 | EP1268802A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 01/02/2003 | EP1268798A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 01/02/2003 | EP1268796A1 Identification of human gaba transporter |
| 01/02/2003 | EP1268794A2 Compositions and methods related to canine igg and canine il-13 receptors |
| 01/02/2003 | EP1268793A2 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/02/2003 | EP1268792A2 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 01/02/2003 | EP1268790A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/02/2003 | EP1268787A2 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 01/02/2003 | EP1268785A2 Gtp-binding protein gamma-12 subunit |
| 01/02/2003 | EP1268783A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 01/02/2003 | EP1268781A2 G12l, a gene associated with the thermal response |
| 01/02/2003 | EP1268780A2 Regulation of human opsin-related g protein-coupled receptor |
| 01/02/2003 | EP1268778A1 Materials and methods relating to a novel splice variant of a na + dependent glutamate transporter |
| 01/02/2003 | EP1268775A1 The high bone mass gene of 11q13.3 |
| 01/02/2003 | EP1268774A2 Identification of essential genes in prokaryotes |
| 01/02/2003 | EP1268773A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 01/02/2003 | EP1268772A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 01/02/2003 | EP1268771A1 Human gata-5 transcription factor |
| 01/02/2003 | EP1268770A1 Method for isolating plasmids from suspended bacterial or yeast cells |
| 01/02/2003 | EP1268764A2 Method for obtaining nucleic acids from an environment sample |
| 01/02/2003 | EP1268761A2 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof |
| 01/02/2003 | EP1268760A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments |
| 01/02/2003 | EP1268757A1 Nitrilase from rhodococcus rhodochrous ncimb 11216 |
| 01/02/2003 | EP1268753A2 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 01/02/2003 | EP1268752A1 Production of lutein in microorganisms |
| 01/02/2003 | EP1268745A2 Method for supply of starter cultures having a consistent quality |
| 01/02/2003 | EP1268550A2 Human fap-alpha-specific antibodies |
| 01/02/2003 | EP1268545A1 Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system |
| 01/02/2003 | EP1268544A2 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 01/02/2003 | EP1268543A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 01/02/2003 | EP1268541A1 7 human ovarian and ovarian cancer associated proteins |
| 01/02/2003 | EP1268540A2 Proteins amf-1 to amf-10 and nucleic acids encoding same |
| 01/02/2003 | EP1268536A1 Tcf responsive element |